Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-29T12:06:19.346Z Has data issue: false hasContentIssue false
  • English
  • Français

Mitochondrial Replacement Therapy and Identity: A Comment on an Exchange Between Inmaculada de Melo-Martin and John Harris

Published online by Cambridge University Press:  30 May 2018

SØREN HOLM
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Departments and Columns
Information
Cambridge Quarterly of Healthcare Ethics , Volume 27 , Issue 3 , July 2018 , pp. 487 - 491
Copyright
Copyright © Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Notes

1. de Melo-Martín, I. When the milk of human kindness becomes a luxury (and untested) good. Cambridge Quarterly of Healthcare Ethics. 2017;26(1):159–65.Google Scholar

2. Harris, J. How to welcome new technologies: some comments on the article by Inmaculada de Melo-Martin. Cambridge Quarterly of Healthcare Ethics 2017;26(1):166–72.CrossRefGoogle Scholar

3. Harris, J. Germline modification and the burden of human existence. Cambridge Quarterly of Healthcare Ethics 2016;25(1):6–18.Google Scholar

4. See note 1, de Melo-Martín 2017, at 160.

5. See note 2, Harris 2017, at 166–7.

6. See note 3, Harris 2016, at 11.

7. Parfit, D. Reasons and Persons. Oxford: Oxford University Press; 1986.Google Scholar

8. Tuppen, HA, Blakely, EL, Turnbull, DM, Taylor, RW. Mitochondrial DNA mutations and human disease. Biochimica et Biophysica Acta 2010;1797(2):113–28, at 117.CrossRefGoogle ScholarPubMed

9. I owe this argument to Iain Brassington.

10. See note 8, Tuppen et al. 2010, at 117.

11. Schapira AH. Mitochondrial disease. The Lancet 2006;368(9529):70–82.

12. See note 3, Harris 2016.

13. Nuffield Council on Bioethics. Novel Techniques for the Prevention of Mitochondrial DNA Disorders: An Ethical Review. London: Nuffield Council on Bioethics; 2012, at 53.

14. See note 2, Harris 2017.

15. See note 3, Harris 2016.